Joe Tippens – My Journey: From Crisis to Strategy (2026)

Other · Joe Tippens · November 19, 2026

Joe Tippens, 2026-11-19: Tippens's own timeline presentation states that while he self-administered fenbendazole he also stayed on the immunotherapy trial he had been enrolled in, and that the trial ended in September 2017.

No clinical trials. No guarantees. I also stayed on the immunotherapy trial.

Section: January 2017, The Leap of Faith (unpaginated)

Joe Tippens, 2026-11-19: Tippens's own timeline presentation states that while he self-administered fenbendazole he also stayed on the immunotherapy trial he had been enrolled in, and that the trial ended in September 2017. Patient-reported, not independently verified. This is the document that answers the 'what else was he on' question in his own words: fenbendazole plus Theracurmin, vitamin E and Avemar alongside 'the immunotherapy trial'. Timeline as published: diagnosis Aug 2016 (small-cell lung cancer), treatment Sep 2016, metastasis Jan 2017, protocol Jan 2017, scan clear May 2017, disclosure Sep 2017 ('Six months clear. Trial over. I finally told my oncologist everything.'), 1 year Apr 2018, sharing 2019, 5 years 2022. The page names Dr Stephen Hahn as his radiation oncologist. The trial is not identified by name or registry number anywhere on the page, and no registry record for it was located in this run – record that as a gap. Access date 2026-11-19, page undated. access date, page undated. Study type: other.